$10.06
-0.20 (-1.95%)
Open$10.32
Previous Close$10.26
Day High$10.36
Day Low$9.85
52W High$14.51
52W Low$5.90
Volume—
Avg Volume893.4K
Market Cap651.76M
P/E Ratio—
EPS$-1.22
SectorPharmaceuticals
Analyst Ratings
Buy
26 analysts
Price Target
+558.3% upside
Current
$10.06
$10.06
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 239.96M | 190.50M | 233.97M |
| Net Income | -73,831,874 | -52,753,800 | 39.13M |
| Profit Margin | -30.8% | -29.2% | 16.7% |
| EBITDA | -105,908,183 | -79,876,765 | 67.61M |
| Free Cash Flow | — | — | 28.90M |
| Rev Growth | +26.0% | +26.0% | +1.6% |
| Debt/Equity | 0.00 | 0.00 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |